Findings

What do systematic reviews say?

21 questions · 21 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 4.8%Low 10 · 47.6%Moderate 10 · 47.6%High 0 · 0%

Adverse events · Adult patients with active ulcerative colitis

Budesonide MMX® 9 mg showed no clear difference in adverse events compared with placebo (moderate certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 1.09 [0.95, 1.26]
3 studies · 971 participants
Moderate